Indoco Remedies Limited (NSE:INDOCO)
India · Delayed Price · Currency is INR 260.10
+5.85 (2.30%)
Sep 11, 2026, 3:29 PM IST
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 24.28 billion as of September 11, 2026. Its market cap has decreased by -4.94% in one year.
Market Cap
24.28B
Enterprise Value
34.77B
Revenue
18.73B
Ranking
n/a
PE Ratio
431.22
Stock Price
260.10
ChartMarket Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 24.28B, an increase of 420.98%. That is a compound annual growth rate of 7.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 24.28B | 12.18% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 63.90B |
| Orchid Pharma | 51.54B |
| RPG Life Sciences | 46.02B |
| Solara Active Pharma Sciences | 34.12B |
| Ind-Swift Laboratories | 32.83B |
| Sakar Healthcare | 24.86B |
| Windlas Biotech | 23.31B |
| Beta Drugs | 21.06B |